In a regulatory filing, the maker of implantable heart devices, St. Jude Medical Inc., reported that the Department of Justice is investigating whether St. Jude violated the False Claims Act by paying doctors and health care facilities to implant its heart devices. St. Jude is reportedly cooperating with the investigation.
In 2011, St. Jude paid $16 million to settle a civil suit alleging that the company used a postmarket study to pay participating doctors as much as as $2,000 per patient in an effort to increase sales of its implantable cardioverter defibrillators (ICDs) and pacemakers.
[1] United States Securities and Exchange Commision Form 10-Q, St. Jude Medical, Inc., File No: 1-12441, May 6, 2014.
[2] Wood, S. "DOJ Investigating St Jude Cardiac 'Kickback' Scheme," Medscape, May 8, 2014.
[3] Wood, S. "St Jude Pays $16M to Settle Kickback Claims Relating to ICD, Pacemaker Use," Medscape, January 21, 2011.
In 2011, St. Jude paid $16 million to settle a civil suit alleging that the company used a postmarket study to pay participating doctors as much as as $2,000 per patient in an effort to increase sales of its implantable cardioverter defibrillators (ICDs) and pacemakers.
[1] United States Securities and Exchange Commision Form 10-Q, St. Jude Medical, Inc., File No: 1-12441, May 6, 2014.
[2] Wood, S. "DOJ Investigating St Jude Cardiac 'Kickback' Scheme," Medscape, May 8, 2014.
[3] Wood, S. "St Jude Pays $16M to Settle Kickback Claims Relating to ICD, Pacemaker Use," Medscape, January 21, 2011.
RSS Feed
